Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Early cancer detection startup Craif raises $22M in Series C funding led by X&KSK to expand into the U.S. market and enhance R&D efforts.
Amount Raised
$22 Million
Round Type
Series C
BunkyoBiotechnologyInvestors
Description
Craif has secured $22 million in Series C funding to further develop its AI-powered early cancer detection software using microRNA. The funding, led by existing investor X&KSK, aims to enhance its presence in the U.S. market and bolster research and development efforts. This brings Craif’s total funds raised to $57 million
Fundz sees it the moment Craif raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Craif raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.